key: cord-0794869-i77mhhwn
authors: Johnson, K. E.; Woody, S.; Lachmann, M.; Fox, S. J.; Klima, J.; Hines, T. S.; Meyers, L. A.
title: Early estimates of SARS-CoV-2 B.1.1.7 variant emergence in a university setting
date: 2021-03-09
journal: nan
DOI: 10.1101/2021.03.05.21252541
sha: 1b84e610d35f58b8b105a1cba33536dd249c6fed
doc_id: 794869
cord_uid: i77mhhwn

Recent identification of the highly transmissible novel SARS-CoV-2 variant in the United Kingdom (B.1.1.7) has raised concerns for renewed pandemic surges worldwide 1,2. B.1.1.7 was first identified in the US on December 29, 2020 and may become dominant by March 2021 3. However, the regional prevalence of B.1.1.7 is largely unknown because of limited molecular surveillance for SARS-CoV-2 4. Quantitative PCR data from a surveillance testing program on a large university campus with roughly 30,000 students provides local situational awareness at a pivotal moment in the COVID-19 pandemic.

We estimate the prevalence of B. 1 

We estimate that the relative frequency of B.1.1.7 is growing logistically at a daily rate of transmissible as the wildtype 1 , we project that its emergence will lead to 77% [95%CI:

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 9, 2021. ; https://doi.org/10.1101/2021.03.05.21252541 doi: medRxiv preprint 39-140%] more cumulative infections during the spring semester than in the absence of the variant.

Surveillance testing conducted by a large public university located in a metropolitan area with a population over two million indicates that B.1.1.7 is rapidly becoming the dominant variant and has the potential to drive a major surge in infections during the spring 2021 within a community not likely to be widely vaccinated before summer 2021. For this study, we assume that daily SARS-CoV-2 specimens are from a representative sample of the UT community and that B.1.1.7 constitutes a fixed proportion of SGTF . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 9, 2021. ; specimens over time. We discuss possible biases resulting from these assumptions in the supplement. 

Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in

International risk of the new variant COVID-19 importations originating in the United Kingdom

Emergence of SARS-CoV-2 B.1.1.7 Lineage -United States

Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data